bioRxivMolecular BiologyPreprint
The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice: a new factor in the microbiome-host interaction.
Nathan DebunneiD, Evelien WynendaeleiD, Yorick JanssensiD, Anton De SpiegeleeriD, Frederick VerbekeiD, Liesa TackiD, Sophie Van WeldeniD, Evy GoossensiD, Daniel KnappeiD, Ralf HoffmanniD, Christophe Van de WieleiD, Debby LaukensiD, Peter Van EenooiD, Filip Van ImmerseeliD, Olivier De WeveriD, Bart M. J. De SpiegeleeriD
Abstract
BackgroundColorectal cancer, one of the most common malignancies worldwide, is associated with a high mortality rate, mainly caused by metastasis. Comparative metagenome-wide analyses between healthy individuals and cancer patients suggest a role for the human intestinal microbiota. Nevertheless, which microbial molecules are involved in this communication is largely unknown, with current studies mainly focusing on short chain fatty acids and amino acid metabolites as potential mediators. However, quorum sensing peptides are not yet considered in this microbiome-host interaction: their in vivo presence nor any in vivo host-effect have been reported. ResultsFor the first time, we showed that a quorum sensing peptide metabolite, EntF* produced by intestinal microbiota (E. faecium), is present in the blood circulation of mice. Moreover, it significantly promotes colorectal cancer metastasis in vivo, with metastatic lesions found in both liver and lung tissues, using an orthotopic mice model evaluating bioluminescence as well as macroscopic and microscopic presence of metastatic tumour nodules. In vitro tests on E-cadherin expression levels thereby indicated that the first, second, sixth and tenth amino acid of EntF* were critical for the epithelial-mesenchymal transition (EMT) effect, responsible for tumour metastasis. ConclusionThis paper adds a new group of molecules, the quorum sensing peptides, as an additional causative factor explaining the microbiome-host interaction. The presence of a selected quorum sensing peptide (metabolite) in the mouse was proven for the first time and its in vivo effect on colorectal metastasis was demonstrated. We anticipate our in vivo results to be a starting point for broader microbiome-health investigations, not only limited to colorectal cancer metastasis, but also for developing novel bio-therapeutics in other disease areas, giving due attention to the QSP produced by the microbiome.
- Citations
- 6
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Primary tumor microbiomes predict distant metastasis of colorectal cancer
Bishal Parajuli, Vishal Midya, … Dustin E. Bosch·npj Precision OncologyPeer-reviewed·Nov 24, 2025
- Fusobacterium nucleatum host cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration
M. A. Casasanta, C. C. Yoo, … D. J. Slade·bioRxiv·Jan 15, 2020
- Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
J. Jones, Q. Shi, … I. L. Brito·bioRxiv·Apr 3, 2023
- Gut microbiome derived folate metabolite suppresses colorectal cancer progression
Rebecca Danner, Juyeong Cho, … Snehal N. Chaudhari·bioRxiv·Jul 15, 2026
- Quorum Sensing Modulates Bacterial Virulence and Colonization Dynamics During an Enteric Infection
J. Pena-Diaz, S. E. Woodward, … B. B. Finlay·bioRxiv·Mar 14, 2023
- Fusobacterium sphaericum sp. nov., isolated from a human colon tumor, adheres to colonic epithelial cells and induces IL-8 secretion
M. A. Zepeda-Rivera, Y. Eisele, … S. Bullman·bioRxiv·Jun 16, 2023